Goal of the analysis:
Assess how participation in bundled payment or value-based care programs will affect a medical device’s adoption, reimbursement, and overall market viability. Determine opportunities and risks for device manufacturers in a healthcare environment that prioritizes cost-effectiveness and clinical outcomes over volume.
Data required:
- Information about specific bundled payment initiatives or value-based care models (for example, CMS Bundled Payments for Care Improvement (BPCI), accountable care organizations (ACOs))
- Relevant reimbursement rates and payment structures tied to episodes of care
- Clinical outcomes data and real-world evidence demonstrating cost savings or improved patient outcomes
- Hospital and physician practice patterns, including utilization data of similar devices under bundled arrangements
- Device pricing, including total cost of ownership or per-episode cost
- Feedback from payers, providers, and healthcare administrators on the perceived value of the device
Detailed step-by-step instruction on how to conduct the analysis:
- Identify bundled payment and value-based care programs relevant to the device. Determine which programs or payer initiatives cover the condition or procedure in which the device is used.
- Review payment methodologies and episodes of care. Understand how reimbursements are structured (for example, a single payment for a 90-day episode of care), including cost-sharing mechanisms.
- Map clinical workflows. Pinpoint where the device fits into the patient’s care pathway and how it can influence overall costs, length of stay, or complication rates within the episode.
- Analyze economic and outcomes data. Review available real-world evidence or clinical trial data indicating potential cost savings or outcomes improvements associated with the device.
- Compare against standard of care. Benchmark the device’s cost-effectiveness, safety, and efficacy with the current treatment or device typically used in these programs.
- Assess provider incentives and barriers. Investigate how hospitals, physicians, and post-acute providers are compensated under the bundled payment, and identify factors that may support or hinder adoption of the device.
- Quantify financial impact. Estimate how using the device could alter bundled payment economics—such as reducing readmissions or decreasing average episode costs—and whether it increases profitability for providers.
- Summarize findings and develop strategies. Outline how the device can be positioned as part of a value-based solution, specifying any data gaps, stakeholder engagement needs, or pricing considerations.
Format of the output of analysis:
- A written report detailing the impact of specific bundled payment programs on device adoption and reimbursement
- A financial model estimating cost savings or outcome improvements when the device is used in the value-based care setting
- A comparison matrix illustrating how the device performs relative to standard of care under bundled payment rules
- An executive summary highlighting market opportunities, key risks, and recommended action steps
How to interpret results:
- If the analysis shows that the device reduces total episode costs or improves quality metrics, it is well-suited for success in bundled payment models.
- Neutral or negative financial impact may indicate that further data or improved device functionality is needed to appeal to providers in value-based arrangements.
- Provider adoption often depends on aligning device benefits with tangible improvements in care delivery, cost reduction, and patient outcomes.
Steps a company can take to improve on this measure:
- Generate robust clinical and economic evidence that demonstrates the device’s cost-effectiveness within an episode of care.
- Collaborate with payers and healthcare systems to pilot the device in a value-based setting, gathering real-world data to support broader adoption.
- Adjust pricing and contracting strategies (for example, risk-sharing agreements) to align with bundled payment structures.
- Provide education and support to providers on how the device can help meet or exceed quality measures within a value-based care environment.
- Continuously monitor and update economic models to reflect changes in reimbursement rules and evolving clinical best practices.
